Decreasing Systemic Toxicity Via Transdermal Delivery of Anticancer Drugs

E-ISSN： 1875-5453|9|7|592-597

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.9, Iss.7, 2008-09, pp. : 592-597

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advances in Nanocarriers for Anticancer Drugs Delivery

Current Medicinal Chemistry, Vol. 23, Iss. 20, 2016-08 ,pp. : 2159-2187

Bentham Science Publishers

Access to resources Recommend Favorite

Nanocrystals Technology for Transdermal Delivery of Water-Insoluble Drugs

Current Drug Delivery, Vol. 15, Iss. 9, 2018-11 ,pp. : 1221-1229

Bentham Science Publishers

Access to resources Recommend Favorite

Nanostructured Systems for the Organelle-specific Delivery of Anticancer Drugs

Mini Reviews in Medicinal Chemistry, Vol. 17, Iss. 3, 2017-01 ,pp. : 224-236

Bentham Science Publishers

Access to resources Recommend Favorite

Simple Rules Defining the Potential of Compounds for Transdermal Delivery or Toxicity

By Magnusson Beatrice M. Pugh W. John Roberts Michael S.

Pharmaceutical Research, Vol. 21, Iss. 6, 2004-06 ,pp. : 1047-1054

Springer Publishing Company

Access to resources Recommend Favorite

An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs

By Phan Viet Hong Tan Cindy Rittau Anneliese Xu Hongmei McLachlan Andrew J Clarke Stephen J

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 11, 2011-11 ,pp. : 1395-1410

Informa Healthcare

Access to resources Recommend Favorite